BR100 Increased By (0.66%)
BR30 Increased By (0.37%)
KSE100 Increased By (0.44%)
KSE30 Increased By (0.42%)
AGHA 7.78 Increased By ▲ 0.03 (0.39%)
BECO 5.19 No Change ▼ 0.00 (0%)
BML 58.00 Decreased By ▼ -0.66 (-1.13%)
BOP 34.16 Increased By ▲ 0.47 (1.4%)
CNERGY 10.54 Decreased By ▼ -0.07 (-0.66%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.70 Increased By ▲ 0.96 (1.79%)
FFL 16.68 Increased By ▲ 0.22 (1.34%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.38 Increased By ▲ 0.10 (1.37%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.58 Decreased By ▼ -0.07 (-0.24%)
MLCF 95.35 Decreased By ▼ -1.01 (-1.05%)
NBP 203.70 Increased By ▲ 0.17 (0.08%)
NCPL 57.80 Increased By ▲ 0.95 (1.67%)
NPL 69.00 Increased By ▲ 1.69 (2.51%)
OGDC 316.89 Decreased By ▼ -1.33 (-0.42%)
PACE 10.74 Increased By ▲ 0.11 (1.03%)
PAEL 42.81 Increased By ▲ 1.04 (2.49%)
PIBTL 16.84 Increased By ▲ 0.03 (0.18%)
PPL 220.24 Increased By ▲ 0.07 (0.03%)
PRL 50.75 Increased By ▲ 1.70 (3.47%)
PTC 70.62 Increased By ▲ 0.61 (0.87%)
SSGC 28.40 Decreased By ▼ -0.74 (-2.54%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.85 Increased By ▲ 0.03 (0.34%)
TPL 18.25 Increased By ▲ 1.08 (6.29%)
TPLP 12.94 Increased By ▲ 0.43 (3.44%)
TREET 22.79 Increased By ▲ 0.20 (0.89%)
TRG 59.92 Decreased By ▼ -0.30 (-0.5%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published Updated
By

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed for this article.